# Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease

> **NCT00152620** · NA · TERMINATED · sponsor: **University of Chicago** · enrollment: 40 (—)

## Conditions studied

- Inflammatory Bowel Disease (IBD)

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT00152620
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 40 (—)
- **Why stopped:** study completed
- **Last updated:** 2013-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152620, "Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00152620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*